Recognising the true impact of ATTR-CM on your patients

Open Access

Recognising the true impact of ATTR-CM on your patients

Session: The journey to improved outcomes in transthyretin amyloid cardiomyopathy (ATTR-CM)

Topic: Cardiac Amyloidosis

Speaker: Assistant Professor N. Ajmone Marsan (Leiden, NL) Professor T. Damy (Creteil, FR) Doctor P. Garcia-Pavia (Majadahonda, ES) Professor P. Elliott (London, GB)

About the speakers

Assistant Professor Nina Ajmone Marsan

Leiden University Medical Center, Leiden (Netherlands (The))

61 presentations

29 followers

Professor Thibaud Damy

University Hospital Henri Mondor, Creteil (France)

37 presentations

1 follower

Doctor Pablo Garcia-Pavia

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda (Spain)

62 presentations

14 followers

Professor Perry Mark Elliott

University College London, London (United Kingdom of Great Britain & Northern Ireland)

67 presentations

26 followers

3 more presentations in this session

When should ATTR-CM be suspected and how to diagnose it

Speaker: Doctor P. Garcia-Pavia (Majadahonda, ES) Professor T. Damy (Creteil, FR) Assistant Professor N. Ajmone Marsan (Leiden, NL) Professor P. Elliott (London, GB)

Access

Managing ATTR-CM: from clinical trials to real-world experiences

Speaker: Professor P. Elliott (London, GB) Professor T. Damy (Creteil, FR) Assistant Professor N. Ajmone Marsan (Leiden, NL) Doctor P. Garcia-Pavia (Majadahonda, ES)

Access

Q&A

Access

Access the full session

The journey to improved outcomes in transthyretin amyloid cardiomyopathy (ATTR-CM)

Speakers: Assistant Professor N. Ajmone Marsan, Professor T. Damy, Doctor P. Garcia-Pavia, Professor P. Elliott, Doctor P. Garcia-Pavia...

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources